Platelets support a protective immune response to LCMV by preventing splenic necrosis

Blood

Volumn 121, Issue 6, 2013, Pages 940-950

  Loria, Gilbert David ^a,b   Romagnoli, Pablo A ^a   Moseley, Nelson B ^a   Rucavado, Alexandra ^b   Altman, John D ^a  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCOPROTEIN IIB MONOCLONAL ANTIBODY; THROMBOPOIETIN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HEMOSTASIS; HISTOLOGY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE MICROSCOPY; INNATE IMMUNITY; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN DISEASE; SPLEEN NECROSIS; THROMBOCYTE; THROMBOCYTE COUNT; VIRUS IMMUNITY; VIRUS REPLICATION;

EID: 84873571986     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-08-376822     Document Type: Article

References (43)

1. Marty AM, Jahrling PB, Geisbert TW. Viral hemorrhagic fevers. Clin Lab Med. 2006;26(2):345-386, viii. (Pubitemid 43947403)
2. Chosewood LC, Wilson DE. Biosafety in microbiological and biomedical laboratories. 5th Ed. Washington, DC: US Government Printing Office; 2009.
3. Binder D, Fehr J, Hengartner H, Zinkernagel RM. Virus-induced transient bone marrow aplasia: Major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus. J Exp Med. 1997;185(3):517-530. (Pubitemid 27078370)
4. Pozner RG, Ure AE, Jaquenod de Giusti C, et al. Junín virus infection of human hematopoietic progenitors impairs in vitro proplatelet formation and platelet release via a bystander effect involving type I IFN signaling. PLoS Pathog. 2010;6(4): e1000847.
5. Cummins D. Arenaviral haemorrhagic fevers. Blood Rev. 1991;5(3):129-137.
6. Geisbert TW, Young HA, Jahrling PB, Davis KJ, Kagan E, Hensley LE. Mechanisms underlying coagulation abnormalities in Ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis. 2003;188(11):1618-1629. (Pubitemid 38010671)
7. Mahanty S, Bray M. Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect Dis. 2004;4(8): 487-498. (Pubitemid 39077918)
8. Moraz ML, Kunz S. Pathogenesis of arenavirus hemorrhagic fevers. Expert Rev Anti Infect Ther. 2011;9(1):49-59.
9. Sanchez A, Lukwiya M, Bausch D, et al. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol. 2004;78(19):10370-10377. (Pubitemid 39258362)
10. Fischer SA, Graham MB, Kuehnert MJ, et al. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med. 2006;354(21):2235-2249. (Pubitemid 43788138)
11. Montali RJ, Connolly BM, Armstrong DL, Scanga CA, Holmes KV. Pathology and immunohistochemistry of callitrichid hepatitis, an emerging disease of captive new world primates caused by lymphocytic choriomeningitis virus. Am J Pathol. 1995; 147(5):1441-1449.
12. Lukashevich IS, Tikhonov I, Rodas JD, et al. Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation. J Virol. 2003;77(3):1727-1737. (Pubitemid 36109984)
13. Zapata JC, Pauza CD, Djavani MM, et al. Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever. Antiviral Res. 2011;92(2):125-138.
14. Oldstone MB, Campbell KP. Decoding arenavirus pathogenesis: essential roles for alpha-dystroglycanvirus interactions and the immune response. Virology. 2011;411(2):170-179.
15. Kim JV, Kang SS, Dustin ML, McGavern DB. Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature. 2009;457(7226):191-195.
16. Zajac AJ, Blattman JN, Murali-Krishna K, et al. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med. 1998;188(12):2205-2213. (Pubitemid 29028493)
17. Cao W, Henry MD, Borrow P, et al. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science. 1998;282(5396):2079-2081. (Pubitemid 29001263)
18. Bergthaler A, Flatz L, Hegazy AN, et al. Viral replicative capacity is the primary determinant of lymphocytic choriomeningitis virus persistence and immunosuppression. Proc Natl Acad Sci U S A. 2010;107(50):21641-21646.
19. Sullivan BM, Emonet SF, Welch MJ, et al. Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence. Proc Natl Acad Sci U S A. 2011;108(7): 2969-2974.
20. Sevilla N, Kunz S, Holz A, et al. Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J Exp Med. 2000; 192(9):1249-1260.
21. Mueller SN, Matloubian M, Clemens DM, et al. Viral targeting of fibroblastic reticular cells contributes to immunosuppression and persistence during chronic infection. Proc Natl Acad Sci U S A. 2007;104(39):15430-15435. (Pubitemid 47502934)
22. Matloubian M, Kolhekar SR, Somasundaram T, Ahmed R. Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus. J Virol. 1993;67(12):7340-7349. (Pubitemid 23343862)
23. Borrow P, Evans CF, Oldstone MB. Virus-Induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J Virol. 1995;69(2):1059-1070.
24. Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, Oldstone MB. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med. 2006;12(11):1301-1309. (Pubitemid 44706933)
25. Ejrnaes M, Filippi CM, Martinic MM, et al. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med. 2006;203(11): 2461-2472. (Pubitemid 44664616)
26. Barber DL, Wherry EJ, Masopust D, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2006;439(7077): 682-687. (Pubitemid 43237609)
27. Tinoco R, Alcalde V, Yang Y, Sauer K, Zuniga EI. Cell-Intrinsic transforming growth factor-beta signaling mediates virus-specific CD8 T cell deletion and viral persistence in vivo. Immunity. 2009; 31(1):145-157.
28. Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol. 2003;77(8):4911-4927. (Pubitemid 36402840)
29. Iannacone M, Sitia G, Isogawa M, et al. Platelets prevent IFN-alpha/beta-induced lethal hemorrhage promoting CTL-dependent clearance of lymphocytic choriomeningitis virus. Proc Natl Acad Sci U S A. 2008;105(2):629-634. (Pubitemid 351171759)
30. Goerge T, Ho-Tin-Noe B, Carbo C, et al. Inflammation induces hemorrhage in thrombocytopenia. Blood. 2008;111(10):4958-4964.
31. Rucavado A, Soto M, Kamiguti AS, et al. Characterization of aspercetin, a platelet aggregating component from the venom of the snake Bothrops asper which induces thrombocytopenia and potentiates metalloproteinase-induced hemorrhage. Thromb Haemost. 2001;85(4):710-715. (Pubitemid 32293709)
32. Murali-Krishna K, Altman JD, Suresh M, et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity. 1998;8(2):177-187. (Pubitemid 28123745)
33. Vogel SN, English KE, O'Brien AD. Silica enhancement of murine endotoxin sensitivity. Infect Immun. 1982;38(2):681-685. (Pubitemid 12002690)
34. Recher M, Lang KS, Hunziker L, et al. Deliberate removal of T cell help improves virus-neutralizing antibody production. Nat Immunol. 2004;5(9): 934-942. (Pubitemid 39276238)
35. Ho-Tin-NoéB, Goerge T, Cifuni SM, Duerschmied D, Wagner DD. Platelet granule secretion continuously prevents intratumor hemorrhage. Cancer Res. 2008;68(16):6851-6858.
36. Ho-Tin-NoéB, Demers M, Wagner DD. How platelets safeguard vascular integrity. J Thromb Haemost. 2011;9(suppl 1):56-65.
37. Ho-Tin-NoéB, Carbo C, Demers M, Cifuni SM, Goerge T, Wagner DD. Innate immune cells induce hemorrhage in tumors during thrombocytopenia. Am J Pathol. 2009;175(4):1699-1708.
38. Lang PA, Contaldo C, Georgiev P, et al. Aggravation of viral hepatitis by platelet-derived serotonin. Nat Med. 2008;14(7):756-761. (Pubitemid 351951519)
39. Schmitt A, Guichard J, MasséJM, Debili N, Cramer EM. Of mice and men: comparison of the ultrastructure of megakaryocytes and platelets. Exp Hematol. 2001;29(11):1295-1302. (Pubitemid 33033306)
40. Levin J. The Evolution of Mammalian Platelets. In: Michelson AD, ed. Platelets. Amsterdam, The Netherlands: Academic Press/Elsevier; 2007:3-22.
41. Gowen BB, Holbrook MR. Animal models of highly pathogenic RNA viral infections: hemorrhagic fever viruses. Antiviral Res. 2008;78(1): 79-90. (Pubitemid 351381175)
42. de Sauvage FJ, Carver-Moore K, Luoh SM, et al. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med. 1996;183(2):651-656. (Pubitemid 26059523)
43. Gurney AL, Carver-Moore K, de Sauvage FJ, Moore MW. Thrombocytopenia in c-mpl-deficient mice. Science. 1994;265(5177):1445-1447. (Pubitemid 24306797)